Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Meretek's UBT urea breath test 95% accurate in detection of H. pylori, study shows.

This article was originally published in The Gray Sheet

Executive Summary

MERETEK'S UBT UREA BREATH TEST 95% ACCURATE IN DETECTION OF H. PYLORI, according to a study by David Graham, MD, MACG, Baylor College of Medicine, Houston, et al., published in the April issue of the American Journal of Gastroenterology. The study concludes that the noninvasive Carbon-13 urea breath test "has the potential to be an important tool both in the diagnosis of infection and in patient management after antimicrobial therapy." A combination 510(k)/new drug application for the test kit, submitted in May 1995, is pending at FDA.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005834

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel